Gene-Disorder Association · Article
Gene
SLC18A2Solute Carrier Family 18 Member A2
×
First reported
1996
Supporting publications
13
Manually curatedApproved treatment annotated
Association Review
In brief
The association between SLC18A2 (Solute Carrier Family 18 Member A2) and Parkinson'S Disease is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
13
Compounds
2
Trials
31of 83 via SLC18A2 compounds
Publications
13
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
1 source summary
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Parkinson'S Disease
The disorder
7 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Interventions
Therapeutics
2 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
06
Human studies
Clinical trials
83 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
13 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
08
Provenance
References & sources
13 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access